Search research articles
Contact Us
Filters
Showing results (41-50 of 205) with videos related to
Page
of 21
Sort By:
Neuropsychiatric Disease and Treatment
|
September 8, 2012
Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
Jennifer Kern Sliwa, Cynthia A Bossie, Dong-Jing Fu, et al.
Journal of Patient-Reported Outcomes
|
July 11, 2022
Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray
Heather Rozjabek, Nan Li, Holger Hartmann, et al.
Journal of Affective Disorders
|
March 23, 2013
Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression
Ibrahim Turkoz, Dong-Jing Fu, Cynthia A Bossie, et al.
International Clinical Psychopharmacology
|
July 20, 2016
Benefit-risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia
Bennett Levitan, Michael Markowitz, Ibrahim Turkoz, et al.
Frontiers in Neurology
|
February 27, 2019
Neuro-Behavioral Status and the Hippocampal Expression of Metabolic Associated Genes in Wild-Type Rat Following a Ketogenic Diet
Ya Ling, Dan-Dan Wang, Yu-Xiao Sun, et al.
CNS Spectrums
|
July 29, 2022
Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE
Ibrahim Turkoz, Oliver Lopena, Giacomo Salvadore, et al.
Clinical and Translational Science
|
April 2, 2026
Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science
Matthijs W van Hoogdalem, Dong-Jing Fu, Wayne C Drevets, et al.
Annals of General Psychiatry
|
July 13, 2013
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Michael Markowitz, Dong-Jing Fu, Bennett Levitan, et al.
Frontiers in Neuroscience
|
September 26, 2019
Long-Term Effects of Zinc Deficiency and Zinc Supplementation on Developmental Seizure-Induced Brain Damage and the Underlying GPR39/ZnT-3 and MBP Expression in the Hippocampus
Ni-Na Chen, Dong-Jing Zhao, Yu-Xiao Sun, et al.
Therapeutic Advances in Psychopharmacology
|
August 29, 2013
Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial
Cynthia A Bossie, Dong-Jing Fu, Jennifer Kern Sliwa, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 205) with videos related to
Sort By:
Page
of 21
Neuropsychiatric Disease and Treatment
|
September 8, 2012
Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
Jennifer Kern Sliwa, Cynthia A Bossie, Dong-Jing Fu, et al.
Journal of Patient-Reported Outcomes
|
July 11, 2022
Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray
Heather Rozjabek, Nan Li, Holger Hartmann, et al.
Journal of Affective Disorders
|
March 23, 2013
Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression
Ibrahim Turkoz, Dong-Jing Fu, Cynthia A Bossie, et al.
International Clinical Psychopharmacology
|
July 20, 2016
Benefit-risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia
Bennett Levitan, Michael Markowitz, Ibrahim Turkoz, et al.
Frontiers in Neurology
|
February 27, 2019
Neuro-Behavioral Status and the Hippocampal Expression of Metabolic Associated Genes in Wild-Type Rat Following a Ketogenic Diet
Ya Ling, Dan-Dan Wang, Yu-Xiao Sun, et al.
CNS Spectrums
|
July 29, 2022
Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE
Ibrahim Turkoz, Oliver Lopena, Giacomo Salvadore, et al.
Clinical and Translational Science
|
April 2, 2026
Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science
Matthijs W van Hoogdalem, Dong-Jing Fu, Wayne C Drevets, et al.
Annals of General Psychiatry
|
July 13, 2013
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Michael Markowitz, Dong-Jing Fu, Bennett Levitan, et al.
Frontiers in Neuroscience
|
September 26, 2019
Long-Term Effects of Zinc Deficiency and Zinc Supplementation on Developmental Seizure-Induced Brain Damage and the Underlying GPR39/ZnT-3 and MBP Expression in the Hippocampus
Ni-Na Chen, Dong-Jing Zhao, Yu-Xiao Sun, et al.
Therapeutic Advances in Psychopharmacology
|
August 29, 2013
Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial
Cynthia A Bossie, Dong-Jing Fu, Jennifer Kern Sliwa, et al.
Page
of 21